158 related articles for article (PubMed ID: 35056772)
1. Replicates Number for Drug Stability Testing during Bioanalytical Method Validation-An Experimental and Retrospective Approach.
Gniazdowska E; Goch W; Giebułtowicz J; Rudzki PJ
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056772
[TBL] [Abstract][Full Text] [Related]
2. Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teams.
Woolf EJ; McDougall S; Fast DM; Andraus M; Barfield M; Blackburn M; Gordon B; Hoffman D; Inoue N; Marcelin-Jimenez G; Flynn A; LeLacheur R; Reuschel S; Santhanam R; Bennett P; Duncan B; Hayes R; Lausecker B; Sharma A; Togashi K; Trivedi RK; Vago M; White S; Barton H; Dunn JA; Farmen RH; Heinig K; Holliman C; Komaba J; Riccio MF; Thomas E;
AAPS J; 2014 Sep; 16(5):885-93. PubMed ID: 24961918
[TBL] [Abstract][Full Text] [Related]
3. Stability of Drugs, Drug Candidates, and Metabolites in Blood and Plasma.
Reed GA
Curr Protoc Pharmacol; 2016 Dec; 75():7.6.1-7.6.12. PubMed ID: 27960029
[TBL] [Abstract][Full Text] [Related]
4. Bioanalytical method development and validation: Critical concepts and strategies.
Moein MM; El Beqqali A; Abdel-Rehim M
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():3-11. PubMed ID: 27720355
[TBL] [Abstract][Full Text] [Related]
5. Bioanalytical method validation design for the simultaneous quantitation of analytes that may undergo interconversion during analysis.
Jemal M; Xia YQ
J Pharm Biomed Anal; 2000 Jun; 22(5):813-27. PubMed ID: 10815724
[TBL] [Abstract][Full Text] [Related]
6. Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC).
Lowes S; Boterman M; Doig M; Breda M; Jersey J; Lelacheur R; Shoup R; Garofolo F; Dumont I; Martinez S; Needham S; Zimmer J; Caturla MC; Couerbe P; Maltas J; Steffen R; Petrilla J; Safavi A; Awaiye K; Bhatti M; Sheldon C; Schiebl C; Struwe P; Turk D; Sangster T; Pattison C; Fast D; Goodwin L; Kamerud J; Dinan A; Mamelak D; Islam R; Segers R; Lin ZJ; Hillier J; Garofolo W; Folguera L; Zimmer D; Zimmermann T; Pawula M; Moussallie M; de Souza Teixeira L; Rocha T; Allinson J; Jardieu P; Tang D; Gouty D; Wright L; Truog J; Lin J; Yamashita Y; Khan M; Liu Y; Xu A; Lundberg R; Cox C; Breau A; Hayes R; Bigogno C; Schoutsen D; Dilger C; Jonker J; Bouhajib M; Levesque A; Gagnon-Carignan S; Harman J; Nicholson R; Jenkins R; Warren M; Lin MH; Karnik S; De Boer T; Houghton R; Green R; Demaio W; Sable R; Smith K; Siethoff C; Cojocaru L; Allen M; Reuschel S; Gonzalez P; Harter T; Fatmi S; Rock M; Vija J; Sayyarpour F; Malone M; Nowatzke W; Best S; Fang X
Bioanalysis; 2012 Sep; 4(17):2117-26. PubMed ID: 23013394
[TBL] [Abstract][Full Text] [Related]
7. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
[TBL] [Abstract][Full Text] [Related]
8. Analysis of remifentanil with liquid chromatography-tandem mass spectrometry and an extensive stability investigation in EDTA whole blood and acidified EDTA plasma.
Koster RA; Vereecke HE; Greijdanus B; Touw DJ; Struys MM; Alffenaar JW
Anesth Analg; 2015 Jun; 120(6):1235-41. PubMed ID: 25692453
[TBL] [Abstract][Full Text] [Related]
9. Challenges and solutions in the bioanalysis of BMS-986094 and its metabolites including a highly polar, active nucleoside triphosphate in plasma and tissues using LC-MS/MS.
Liu A; Lute J; Gu H; Wang B; Trouba KJ; Arnold ME; Aubry AF; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():29-40. PubMed ID: 26209768
[TBL] [Abstract][Full Text] [Related]
10. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process.
Hubert C; Lebrun P; Houari S; Ziemons E; Rozet E; Hubert P
J Pharm Biomed Anal; 2014 Jan; 88():401-9. PubMed ID: 24176744
[TBL] [Abstract][Full Text] [Related]
11. Bioanalytical method validation: a risk-based approach?
James CA; Breda M; Frigerio E
J Pharm Biomed Anal; 2004 Jun; 35(4):887-93. PubMed ID: 15193733
[TBL] [Abstract][Full Text] [Related]
12. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
Viswanathan CT; Bansal S; Booth B; DeStefano AJ; Rose MJ; Sailstad J; Shah VP; Skelly JP; Swann PG; Weiner R
Pharm Res; 2007 Oct; 24(10):1962-73. PubMed ID: 17458684
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery.
Ackermann BL; Berna MJ; Murphy AT
Curr Top Med Chem; 2002 Jan; 2(1):53-66. PubMed ID: 11899065
[TBL] [Abstract][Full Text] [Related]
14. Validation of bioanalytical chromatographic methods.
Hartmann C; Smeyers-Verbeke J; Massart DL; McDowall RD
J Pharm Biomed Anal; 1998 Jun; 17(2):193-218. PubMed ID: 9638572
[TBL] [Abstract][Full Text] [Related]
15. System suitability in bioanalytical LC/MS/MS.
Briscoe CJ; Stiles MR; Hage DS
J Pharm Biomed Anal; 2007 Jun; 44(2):484-91. PubMed ID: 17433601
[TBL] [Abstract][Full Text] [Related]
16. LC-MS/MS method for the determination of clodronate in human plasma.
Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
[TBL] [Abstract][Full Text] [Related]
17. A Rapid Dilute-and-Shoot UPLC-MS/MS Assay to Simultaneously Measure 37 Drugs and Related Metabolites in Human Urine for Use in Clinical Pain Management.
Dahlin JL; Palte MJ; LaMacchia J; Petrides AK
J Appl Lab Med; 2019 May; 3(6):974-992. PubMed ID: 31639689
[TBL] [Abstract][Full Text] [Related]
18. Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring.
Capiau S; Veenhof H; Koster RA; Bergqvist Y; Boettcher M; Halmingh O; Keevil BG; Koch BCP; Linden R; Pistos C; Stolk LM; Touw DJ; Stove CP; Alffenaar JC
Ther Drug Monit; 2019 Aug; 41(4):409-430. PubMed ID: 31268966
[TBL] [Abstract][Full Text] [Related]
19. A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples.
Jemal M; Ouyang Z; Powell ML
Rapid Commun Mass Spectrom; 2002; 16(16):1538-47. PubMed ID: 12203245
[TBL] [Abstract][Full Text] [Related]
20. From patient to tube: the importance of physiologically relevant quantitative bioanalytical assays.
Summerfield S; Barfield M; Spooner N; White S
Bioanalysis; 2016 Dec; 8(24):2595-2604. PubMed ID: 27884077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
